Ixabepilone + Capecitabine

DRUG2 trials

Sponsors

R-Pharm

Conditions

Breast CancerCancerMetastases

Phase 3

Novel Epothilone Plus Capecitabine Versus Capecitabine Alone in Patients With Advanced Breast Cancer

CompletedNCT00080301

R-PharmBreast Cancer, Metastases

Start: 2003-09-30End: 2008-03-31Updated: 2020-11-02

Epothilone (Ixabepilone) Plus Capecitabine Versus Capecitabine Alone in Patients With Advanced Breast Cancer

CompletedNCT00082433

R-PharmBreast Cancer, Cancer

Start: 2003-11-30End: 2008-03-31Updated: 2020-11-02

Related Papers

Efficacy and Safety of Ixabepilone and Capecitabine in Patients With Advanced Triple-negative Breast Cancer: a Pooled Analysis From Two Large Phase III, Randomized Clinical Trials.

2018-08-0424 citations

Ixabepilone plus capecitabine in advanced breast cancer patients with early relapse after adjuvant anthracyclines and taxanes: a pooled subset analysis of two phase III studies.

2011-09-219 citations

Ixabepilone plus capecitabine in metastatic breast cancer patients with reduced performance status previously treated with anthracyclines and taxanes: a pooled analysis by performance status of efficacy and safety data from 2 phase III studies.

2010-12-0315 citations